Chapter 7. Progesterone Receptor Antagonists
- Prof. Dr. Eckhard Ottow2,
- Dr. Hilmar Weinmann3
Published Online: 19 DEC 2008
DOI: 10.1002/9783527623297.ch7
Copyright © 2008 Wiley-VCH Verlag GmbH & Co. KGaA
Book Title

Nuclear Receptors as Drug Targets
Additional Information
How to Cite
Spitz, I. M. (2008) Progesterone Receptor Antagonists, in Nuclear Receptors as Drug Targets (eds E. Ottow and H. Weinmann), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527623297.ch7
Editor Information
- 2
Bayer Schering Pharma AG, Medicinal Chemistry (S106/345), Müllerstrasse 178, 13342 Berlin, Germany
- 3
Bayer Schering Pharma AG, Medicinal Chemistry (S106/048A), Müllerstrasse 178, 13342 Berlin, Germany
Publication History
- Published Online: 19 DEC 2008
- Published Print: 20 AUG 2008
Book Series:
Book Series Editors:
- Prof. Dr. Raimund Mannhold4,
- Prof. Dr. Hugo Kubinyi5,
- Prof. Dr. Gerd Folkers6
Series Editor Information
- 4
Molecular Drug Research Group, Heinrich-Heine-Universität, Universitätsstrasse 1, 40225 Düsseldorf, Germany
- 5
Donnersbergerstrasse 9, 67256 Weisenheim am Sand, Germany
- 6
Collegium Helveticum, STW/ETH Zurich, 8092 Zurich, Switzerland
ISBN Information
Print ISBN: 9783527318728
Online ISBN: 9783527623297
- Summary
- Chapter
- References
Keywords:
- progesterone receptor antagonists (PAs);
- selective progesterone receptor modulators (SPRMs);
- progesterone receptor modulators (PRMs)
Summary
This chapter contains sections titled:
Introduction
Chemistry
Progesterone Receptor (PR)
Mechanism of Action
Biological Effects of PAs and SPRMs
Clinical Applications
Other Potential Obstetrical and Gynecological Applications
Nongynecological Applications
Side-Effects of Long-Term Administration of PAs and SPRMs
Conclusions
References
